glp 16&1 GLP-1 drugs have taken the world by storm, helping many people lose 11%–16% of their body weight. But a new Cochrane review reveals something surprising: the evidence supporting these blockbuster injections isn't First 90 Days on GLP-1

Isso pode ajudar a preservar a funo das clulas beta ao longo do tempo, retardando a progresso do DM2

The Bottom Line GLP-1 therapies are not just sticking to diabetes and obesity anymore

In addition, this side effect is quite uncommon, with only 36 cases being reported to the United States FDA over a 16-year period

Patients starting semaglutide or other GLP-1 receptor agonists sometimes notice they feel colder than usual, especially in the first few weeks of treatment

For state Medicaid agencies that opt to participate in the model, implementation will be on a rolling basis from May 1, 2026 through January 1, 2027